Market Place
Sourcing Support
All News #Library
Rare Diseases
FDA Approves Label Update For Kite`s Yescarta® In Cns Lymphoma
06 Feb 2026 //
BUSINESSWIRE
RAAP: Alternative Funding Programs Put Rare Patients In Jeopardy
07 Jan 2026 //
PR NEWSWIRE
Gilead Launches New Primary Biliary Cholangitis Campaign
10 Sep 2025 //
FIERCE PHARMA
AbbVie, Gilead, GSK Support Annual Hepatitis Elimination Drive
29 Jul 2025 //
FIERCE PHARMA
Pantherv Rare Partners With Gilead For Distribution Of LIVDELZI®
16 Aug 2024 //
PR NEWSWIRE
Gilead, Ipsen build the case for their PBC drugs at EASL
05 Jun 2024 //
PHARMAPHORUM
FDA fires off a warning on rare cases involving death, adverse liver events
29 Aug 2019 //
ENDPTS
TG Therapeutics’ shares jump as umbralisib wins FDA’s breakthrough status
22 Jan 2019 //
ENDPTS
Gilead`s FXR drug posts positive phase 2 data in rare liver condition
10 Nov 2018 //
FIERCE BIOTECH
Sangamo in $3 billion gene-editing deal with Gilead
23 Feb 2018 //
REUTERS
3 Biotechs With Bulging Pipelines Could Also Become Attractive Takeover Targets
30 Jun 2017 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.